Author Informations

The submission portal for J3C2025 events will open on the 1st October 2024. All submissions must be made through the IFAC Conference Manuscript Management System website at http://ifac.papercept.net/. All papers presented will be recorded as an IFAC Publication. When preparing the paper manuscript, the authors should adhere to the IFAC style files for conference paper. The procedure and guidelines for submitting special session proposals are provided on the conference website.

All submitted papers must be written in English. Only regular papers are accepted at EAAS 2025, ICONS 2025 and TA 2025, which can have a length of up to 8 pages at initial submission. Accepted papers are limited to 6 pages in the conference proceedings at no extra charge; up to two extra pages are allowed for an additional charge.

Author’s kits with style (.cls) files for LaTeX and templates (.dot) for MS-Word are available from the submission website. Go to http://ifac.papercept.net/ and select “Support” for these files and example files, or directly go to the support page. Please do not change the formatting in any way. Copyright Conditions All publication material submitted for presentation at an IFAC-sponsored meeting (Congress, Symposium, Conference, Workshop) must be original and hence cannot be already published, nor can it be under review elsewhere. The authors take responsibility for the material that has been submitted. IFAC-sponsored conferences will abide by the highest standard of ethical behavior in the review process as explained on the Elsevier webpage, and the authors will abide by the IFAC publication ethics guidelines. Accepted papers that have been presented at an IFAC meeting will be published in the proceedings of the event using the open-access IFAC-PapersOnLine series hosted on ScienceDirect. To this end, the author(s) must grant exclusive publishing rights to IFAC under a Creative Commons license when they submit the final version of the paper. The copyright belongs to the authors, who have the right to share the paper in the same terms allowed by the end user license, and retain all patent, trademark and other intellectual property rights (including research data).